The National Foundation for Cancer Research, led by Chairman Joseph F. Franlin and President Sujuan Ba, recruited a delegation of eight U.S. cancer technology start-ups for a successful exploratory mission to China. The companies—ArrayBio, Eutropics, Immix Biopharma, InterLeukin Therapeutics, International Cancer Impact Fund, InVaMet Therapeutics, Nonpareil Biotechnologies and Stromatis Pharma—were…...
The Society for Neuro-Oncology of China has invited Dr. Sujuan Ba, the president and chief operating officer of the National Foundation for Cancer Research (NFCR), to give a lecture at its annual meeting, SNOChina 2018, to be held in Changsha, Hunan on March 16-17, 2018. The Society will present the…...
NFCR President receives the inaugural award from Society for Neuro-Oncology of the Chinese Medical Doctor Association for her outstanding contribution to international cooperation in March 2017. Dr. Jiang Tao, the Chairman of the Society for Neuro-Oncology of the Chinese Medical Doctor Association and the vice director of the department of…...
NFCR’s Dr. Sujuan Ba Energizes Women in Science at CRS Annual Luncheon August 2011 –Sujuan Ba, Ph.D., Chief Operating Officer of the National Foundation for Cancer Research, was the featured speaker at the Controlled Release Society (CRS) Women in Science Forum Luncheon. Dr. Ba described her tenacious climb through the…...
Free Cancer Screening Guidelines
National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
5515 Security Lane, Suite 1105 Rockville, MD 20852
